Pemoline

This classification denotes a cns stimulant with the molecular formula C9H8N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 7GAQ2332NK, chemically known as 4-oxazolidinone, 2-imino-5-phenyl- but more generally known as pemoline, which bears US NIH Compound Identifier 4723. European Medicines Agency schedules Pemoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09657MIG. The term PEMOLINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). World Health Organization schedules pemoline in its Anatomical Therapeutic Chemical (ATC) Classification. PEMOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule pemoline under HS 29349100 and SITC 51579. As of Q4 2014, PEMOLINE remains US FDA's Preferred Term for this commodity. Pemoline bears US NLM identifiers UMLS ID C0030800 and NCI Concept Code C47655. SMILES: O1C(C2CCCCC2)C(=O)N=C1N.